Agarwal Gaurav, Aggarwal Vivek
Department of Endocrine & Breast Surgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow, 226014, India.
World J Surg. 2008 Jul;32(7):1313-24. doi: 10.1007/s00268-008-9579-8.
Benign multinodular goiter is one of the most common endocrine surgical problems. The appropriate surgical procedure for its effective and safe management is a matter of debate. Though seen by some as an overly hazardous procedure because of the risk of recurrent laryngeal nerve injury and damage to parathyroid function, total thyroidectomy has replaced subtotal thyroidectomy as the procedure of choice, as the latter is associated with significant recurrences.
A systemic literature review was undertaken of all available medical literature to evaluate whether total thyroidectomy is the appropriate, safe and effective surgical procedure for benign multinodular goiter.
There is consistent level II-IV evidence that subtotal thyroidectomy results in recurrence in up to 50% patients. Incidental thyroid cancers are detected in 3%-16.6% of apparently benign goiters in numerous studies, mostly providing level IV evidence, one third of which would need further surgical treatment after subtotal thyroidectomy. Studies comparing subtotal thyroidectomy and total thyroidectomy, including two each of prospective randomized and prospective nonrandomized ones, provide level II-IV evidence that permanent complication rates associated with subtotal thyroidectomy and total thyroidectomy are not different, although the rate of transient hypocalcemia is higher with total thyroidectomy. On basis of these findings, a grade B recommendation can be made that subtotal thyroidectomy is associated with significant recurrence of goiter, leaves a small number of incidentally detected thyroid cancers inadequately treated, and provides little significant safety advantage over total thyroidectomy. Grade C recommendations can also be made about total thyroidectomy being a safe and effective procedure for benign multinodular goiters in the hands of expert surgeons, based on the extensive level IV evidence, and limited level II and level III evidence, which show that the risk of permanent vocal cord palsy and hypoparathyroidism associated with total thyroidectomy is below the acceptable 2% rate, but not without exceptions.
Total thyroidectomy is the procedure of choice for the surgical management of benign multinodular goiter.
良性结节性甲状腺肿是最常见的内分泌外科问题之一。对于其有效且安全的治疗,合适的手术方式存在争议。尽管由于喉返神经损伤风险和甲状旁腺功能损害,全甲状腺切除术被一些人视为过于危险的手术,但由于甲状腺次全切除术复发率较高,全甲状腺切除术已取代甲状腺次全切除术成为首选术式。
对所有可得医学文献进行系统回顾,以评估全甲状腺切除术是否是治疗良性结节性甲状腺肿合适、安全且有效的手术方式。
有一致的II-IV级证据表明,甲状腺次全切除术导致高达50%的患者复发。在众多研究中,3%-16.6%的看似良性的甲状腺肿中偶然发现甲状腺癌,多数研究提供IV级证据,其中三分之一在甲状腺次全切除术后需要进一步手术治疗。比较甲状腺次全切除术和全甲状腺切除术的研究,包括两项前瞻性随机研究和两项前瞻性非随机研究,提供II-IV级证据表明,甲状腺次全切除术和全甲状腺切除术相关的永久性并发症发生率并无差异,尽管全甲状腺切除术的短暂性低钙血症发生率更高。基于这些发现,可以做出B级推荐:甲状腺次全切除术与甲状腺肿的显著复发相关,使少数偶然发现的甲状腺癌治疗不充分,且与全甲状腺切除术相比,安全性优势不显著。基于广泛的IV级证据以及有限的II级和III级证据,也可以做出C级推荐:对于专家外科医生而言,全甲状腺切除术是治疗良性结节性甲状腺肿的安全有效术式,这些证据表明全甲状腺切除术相关的永久性声带麻痹和甲状旁腺功能减退风险低于可接受的2%,但并非没有例外。
全甲状腺切除术是良性结节性甲状腺肿手术治疗的首选术式。